Cephalexin-Induced Hemolytic Anemia and Renal Failure: A Case Report and Review of the Literature

头孢氨苄诱发溶血性贫血和肾功能衰竭:病例报告及文献综述

阅读:1

Abstract

Hemolytic anemia is a rare adverse reaction to cephalosporins, and its occurrence in response to cephalexin is even rarer. Cephalexin is a commonly prescribed empiric oral antibiotic for a variety of infections, particularly in the outpatient setting. It is, therefore, important to be aware of this possible adverse reaction to cephalexin for timely intervention and prompt discontinuation of the offending agent. We present a case of a 48-year-old female with no significant past medical history who presented with intermittent hematuria for two days and anuria for one day. She had been seen in the emergency department three days prior for a urinary tract infection and discharged on cephalexin. Her renal function was normal at the time. Upon re-presentation with anuria, her creatinine and hemoglobin had acutely worsened, lactate dehydrogenase was elevated, and haptoglobin was low. Her renal function rapidly deteriorated, and the patient required hemodialysis. Her renal biopsy revealed acute tubular injury with numerous intraluminal hemoglobin casts supporting the diagnosis of drug-induced hemolysis resulting in acute renal failure. The patient achieved full renal recovery within four weeks following prompt discontinuation of cephalexin and timely renal replacement support. This case highlights the importance of considering this rare adverse reaction to cephalexin when a patient presents with findings suggestive of intrarenal acute kidney injury. Early recognition can expedite the diagnostic workup and treatment, potentially improving outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。